Weekly Top Stories: Life Sciences Ontario Ideas to Action Forum Celebrates 15th Year
This week in Canadian healthcare, major provincial investments in life sciences contrast with ongoing challenges in healthcare delivery and access, highlighting the promise and current limitations of our healthcare system. The Life Sciences Ontario (LSO) Ideas to ActionForum marked its 15th anniversary with a sold-out gathering on November 13th atBorden Ladner Gervais LLP, bringing together influential voices from industry,government, and academia. The forum, themed “Reflecting on 15 Years andPowering Ontario’s Hard Pivot to the Future,” emphasized Ontario’sgrowth, innovation, and resilience in the life sciences sector. Deloitte’s Health Futurist Zayna Khayat opened the event with a keynote examining the evolution of health technology while emphasizing the need for system leaders, industry governments, and healthcare providers to fundamentally change their thinking to overcome an epidemic of”nowism.” The forum featured several expert panels addressing core themes shaping the sector: The event culminated with significant announcements from Ontario’s Minister of Economic Development, Job Creation, and Trade, Vic Fedeli. Minister Fedeli hinted that further announcements are coming to support the province’s “hard pivot” to the life sciences. Fedeli highlighted Ontario’s impressive metrics:72,000 current life sciences workers with a goal of reaching 85,000 by 2030, complemented by 70,000 STEM graduates and 85,000 AI graduates. He noted that Ontario hosts 10 of the world’s top pharmaceutical companies conducting clinical trials, reinforcing its potential as a global hub for biomanufacturing and life sciences. Fedeli praised LSO and its leadership, particularly acknowledging Dr. Jason Field, President and CEO of LSO, for his dedication to Ontario’s life sciences growth. While Ontario pushes forward with ambitious life sciences initiatives, a new study reveals significant gaps in current healthcare delivery. Research from the Menopause Foundation of Canada has highlighted a concerning disconnect in women’s healthcare support, finding that approximately half of the Canadian women aged 40-60 feel unprepared for perimenopause/menopause. The findings underscore a critical gap in healthcare delivery, with most respondents reporting that family physicians rarely discuss menopause with them, leading to a sense of being undertreated and underserved by their healthcare providers. Adding to concerns about healthcare access and administration, federal retirees shared their concerns about the recent transition of their dental benefits from Sun Life to Canada Life. The $ 514 million contract switch, affecting approximately 1.7 million federal public servants, retirees, and their dependents, has encountered implementation difficulties.Several retirees experienced frustration due to the transition, citing that they could not reach a call centre agent and were denied medications. The Treasury Board Secretariat (TBS) asserted that lessons learned from the Public Service Health Care Plan transition were applied to facilitate a smoother switch for the dental plan. These developments paint a complex picture of Canadian healthcare; while significant investments promise future innovations, current gaps in healthcare delivery and program administration continue to affect Canadians’ access to essential services. Stay tuned to Delphic Research for further insights into these critical healthcare developments. Book a free consultation today to learn how we can help you understand these trends that might impact your organization or community.
Weekly Top Stories: Trump Victory Signals Potential Shifts in Canada-U.S. Healthcare Relations
As Donald Trump secures his return to the White House, Canada’s healthcare landscape faces potential transformation. From drug pricing to cross-border medical cooperation, stakeholders across the country are preparing for a new chapter in Canada-U.S. healthcare relations. Prime Minister Justin Trudeau’s congratulatory statement emphasized the strong and longstanding partnership between Canada and the U.S., highlighting their shared history and the successful renegotiation of the Canada-U.S.-Mexico Agreement(CUSMA) under Trump’s first term, noting that bilateral trade has surged, reaching over $1.3 trillion in 2023. The Canadian Chamber of Commerce, through president and chief executive officer Candace Laing, reinforced the importance of preserving this economic partnership, noting the $3.6 billion in daily trade while urging close collaboration to resist potential tariffs and trade barriers. As Canadian cabinet ministers call for calm amid Trump’s promises of tariffs and tighter immigration policies, InnovationMinister François-Philippe Champagne has assured industries that Canada’s strategic importance in sectors like critical minerals and energy will remain a priority in future trade negotiations. Provincial leaders are also taking action, with Ontario Premier Doug Ford and Economic Development Minister Vic Fedeli planning a “charm offensive” in Washington and key U.S. states to promote Ontario’s critical minerals, energy, and electric vehicle manufacturing. Meanwhile, Manitoba Premier Wab Kinew has emphasized the value of Manitoba goods and critical minerals for the American defence sector, despite concerns over Trump’s proposed 10% tariffs. The healthcare sector faces particular uncertainty under Trump’s second-term agenda. His campaign hinted at revisiting policies from his first term, including international reference pricing for drugs and potential changes to the Affordable Care Act. Some sectors fear that the U.S. Medicaid program could face cuts as Republicans seek spending reductions to extend Trump’s 2017 tax cuts. However, the program’s shift to private insurers and support from rural hospitals may offer some protection. Analysts discussing these developments in this week’s Canada-U.S. newsletter analysts discussed how Trump’s re-election could challenge Canadian competitiveness, particularly with the threat of new tariffs and trade tensions. Experts warned that Trump’s aggressive economic policies, including tariffs and defence spending demands, could strain Canada’s economy and its relationship with the U.S. However, former New Jersey governor Chris Christie argued that Canada could benefit from aligning more closely with Trump’s pro-growth policies, which emphasize reducing barriers to business and fostering a thriving private sector. Against this backdrop of international uncertainty, Canada’s own healthcare spending is projected to reach unprecedented levels. The Canadian Institute for Health Information’s annual report reveals healthcare expenditures will hit $372 billion in 2024, equating to $9,054 per capita. This 5.7% increase follows a trend of rising health expenditures in recent years, driven by the growing and aging population. The introduction of new federal programs such as dental and Pharmacare plans is expected to further increase costs as more Canadians gain access to essential health services. Health spending is also forecast to account for 12.4% of Canada’s gross domestic product, the highest level outside of the pandemic years. These rising costs mirror growing public concerns. The Salvation Army’s “2024 Canadian Poverty and SocioeconomicAnalysis” reveals healthcare as a primary worry among Canadians, with 59% of respondents ranking it as their top concern. The survey, gathering data from over 1,500 Canadians, indicates that healthcare anxieties extend beyond mere cost-of-living challenges, intertwining with other social issues like housing insecurity at 44%. As Canada navigates these challenges, there’s growing support for innovative healthcare solutions. An online survey by spark*insights reported that about 80% of Canadians deem it crucial for their health benefits plan to cover virtual care. Among 1,815 adult respondents, about two-thirds hope for federal government intervention to encourage employer-provided virtual care benefits. This push for digital health solutions suggests a desire to strengthen Canada’s independent healthcare capabilities amid international uncertainty. Meanwhile, Statistics Canada unveiled in a recent survey that the majority of First Nations People, Métis, and Inuit found it crucial to include Indigenous traditional medicines and wellness practices in healthcare services. The survey also emphasized that nearly one in five Indigenous people experience unfair treatment, racism, or discrimination from healthcare professionals, limiting their access to quality care. As Canada balances international pressures with domestic healthcare priorities, these developments underscore the complex challenges ahead. Stay tuned to Delphic Research for ongoing analysis of how these changes might reshape Canada’s healthcare landscape. Book a free consultation today!
Weekly Top Stories: Ontario Announces Major Healthcare Investments in 2024 Fall Economic Statement
Healthcare funding and accessibility dominated this week’s news, as Ontario announced substantial investments in its Fall Economic Statement. Meanwhile, reports of treatment barriers and care gaps across the country highlight the ongoing challenges in Canada’s evolving healthcare landscape The Ontario government’s 2024 Fall Economic Statement unveiled healthcare investments as part of its broader economic plan. A cornerstone of these initiatives is a $546 million investment in improving primary healthcare, aiming to connect 600,000 people to team-based care. This commitment represents a significant step toward addressing healthcare access issues in the province. In a targeted initiative for those with amyotrophic lateral sclerosis (ALS), the government is committing $13 million over three years to establish a comprehensive provincial program. This funding will support five regional multidisciplinary ALS clinics, including a notable expansion into Northern Ontario, while exploring an assistive devices loan and recycling program for those with physical disabilities. Ontario Premier Doug Ford welcomed ALS Canada to Queen’s Park to discuss the life-changing impact this funding will have on residents battling ALS. Fertility services are also receiving significant attention, with a $150 million investment to expand the Ontario Fertility Program. This expansion will nearly triple access to government-funded IVF cycles, while a new tax credit planned for 2025 will cover 25% of eligible fertility treatment expenses, supported by a $115 million allocation. The province’s commitment to healthcare infrastructure remains substantial, with nearly $50 billion dedicated to this, including $36 billion for over 50 hospital projects and 3,000 new beds. However, these investments have drawn mixed reactions from stakeholders. The Toronto Region Board of Trade expressed support for the investments in high-productivity industries and manufacturing, commending the expansion of the Invest Ontario Fund and ongoing infrastructure projects. However, it advocated for more substantial investments in productive capacity over cash rebates to enhance long-term economic prosperity. The Canadian Life and Health Insurance Association (CLHIA) welcomed the commitment to introduce a new licensing category for managing general agents. This initiative will enhance consumer protection and clarify accountabilities within the insurance industry, ultimately leading to fairer outcomes for Ontarians. In contrast, the Ontario NDP, led by Marit Stiles, criticized the economic statement, arguing that instead of addressing key issues like healthcare access, the provincial government offers only distractions and empty promises. Similarly, the Ontario Liberals, MPP for Ottawa South John Fraser, slammed the statement for prioritizing wealthy insiders over real investments in healthcare and financial relief. Ontario Greens Leader Mike Schreiner also criticized the Ford government for failing to address rising costs, housing shortages, and climate change. On a similar note, Ontario’s community health sector, representing over 200,000 workers, has expressed disappointment over the government’s failure to address a $2 billion wage gap that affects care quality, especially in areas like mental health and addictions, and is calling for investments to close this gap and establish sustainable workforce support through collaborative efforts by associations including Addictions and MentalHealth Ontario (AMHO) among others. These concerns about healthcare access are reflected in national statistics. Canadian think tank SecondStreet reveals that more than 3.2 million Canadians lack access to basic healthcare services, including surgeries and appointments with experts. In Ontario specifically, while waitlist volumes have decreased by 19%, diagnostic waitlist volumes have seen a troubling 32% increase. Breast Cancer Canada’s 2024 progress report also highlights the challenges in cancer care accessibility, highlighting the urgent need for equitable access to breast cancer care across Canada. Some of the gaps identified include accessible routine screening, the financial impact on families, and the latest treatments. The challenges of healthcare access are particularly acute for Canadians with rare diseases. Despite Health Canada’sapproval of innovative treatments for conditions like spinal muscular atrophy(SMA), approximately one million Canadians diagnosed with rare disorders continue to face the lack of treatment access despite approvals from HealthCanada. Innovative treatments such as Spinraza, Zolgensma, and Evrysdi have been approved by the government as safe and effective. However, age limits on these drugs continue to cause financial strain to adults with SMA due to denied coverage. Against this backdrop of healthcare access challenges, the implementation of the Pharmacare Act promises potential relief. The Act aims to reduce financial burdens by providing free access to essential medications, including contraceptives and diabetes medications. However, its success depends on the federal government’s ability to secure agreements with individual provinces and territories. In British Columbia, where free access to contraceptives has been available since 2023, advocacy groups, including the Council of Canadians and AccessBC, shared their concern that the program could be dissolved by an incoming Conservative government if the federal government failed to secure agreements as soon as possible. Book a free consultation today to learn more about how these healthcare developments might impact your organization or community.
Weekly Top Stories: Provincial Support for Pharmacare Remains in Focus as Federal Government Faces Implementation Challenges
The implementation of Pharmacare continues to dominate discussions, while significant investments in research and accessibility initiatives signal progress in other areas of healthcare development. The federal government’s optimism about Pharmacare is being met with mixed reactions across the country as the New Democratic Party (NDP) intensifies its calls for provincial participation. In Ontario, the Ministry of Health Sylvia Jones office revealed that it has yet to be notified by the federal government about the pharmacare deal. While expressing willingness to collaborate, the ministry is requesting more detailed information about the legislation before entering negotiations. Meanwhile, Conservative opposition leader Pierre Poilievre faces criticism for allegedly spreading dubious details about the Pharmacare Act. The pharmacare law is accused of abolishing private insurance plans and eliminating health benefits. The urgency for provincial participation is particularly evident in Newfoundland and Labrador, where NDP Candidate for St. John’s East Mary Shortall is pressing for immediate action to finalize a Pharmacare agreement. The push is backed by compelling data: according to Diabetes Canada, 14% of Newfoundland and Labrador residents are diagnosed with diabetes – notably 4% above the national average. The residents currently spend over $70 million on diabetes coverage alone. The Health Charities Coalition of Canada applauded the passage of Pharmacare, citing the bill as a crucial step towards developing a national formulary and bulk purchasing strategy. Chairperson Elizabeth Myles said that Pharmacare will provide relief to 25% of Canadians forced to choose between affording medications and other basic needs. In a significant development for healthcare research, the Canadian Institutes of Health Research shared that the federal government invested $13.7 million in support of 24 research projects that will tackle under-researched areas of women’s and gender-diverse people’s health. The projects that will receive the fund are focused on polycystic ovary syndrome (PCOS), rural and Indigenous perinatal care and breastfeeding, heart health, gender-based violence, mental health, eating disorders, reproductive care and pregnancy, gender-based violence, cancer and HPV, vestibulodynia, and endometriosis. Meanwhile, several reports revealed that Canadians with non-terminal conditions often seek medical assistance in dying (MAID) due to social reasons such as loneliness, isolation, and fear of homelessness. A report from the Associated Press unveiled that the 2021 expansion of MAID caused an increased application from people in the poorest areas of Ontario. A study by Longwoods Publishing called for deep and sustained deliberation in assisted dying policies in Canada, raising important questions about the intersection of healthcare, social support, and end-of-life decisions. On a forward-looking note, the Speech Accessibility Project, led by the University of Illinois Urbana-Champaign, is expanding its reach into Canada with a new recruitment initiative. The project seeks Canadian adults with Parkinson’s disease, cerebral palsy, and amyotrophicis to participate in research aimed at improving speech recognition systems to better understand diverse speech patterns and disabilities. This initiative holds significant potential for enhancing the quality of life for more than 100,000 Canadians living with Parkinson’s disease and other conditions that affect speech, demonstrating continued progress in making healthcare more accessible to all Canadians. Stay tuned to Delphic Research for further insights into these critical healthcare issues. Book a free consultation today to learn more about how these healthcare trends might impact your organization or community.
Weekly Top Stories: Sharon Blady joins PMPRB as a Board Member; and a $146 million Investment in the Next Phase of Life Sciences Strategy
This week in Canadian healthcare saw significant developments in governance, provincial investments, and ongoing debates about pharmacare implementation. From key appointments to major funding announcements and policy discussions, the healthcare landscape continues to evolve rapidly. Federal Minister of Health Mark Holland announced the appointment of Sharon Blady, former Manitoba health minister, to the Patented Medicine Prices Review Board (PMPRB). Set to serve a five-year term, Blady brings over 15 years of experience in healthcare and public policy to the role with a particular focus on mental health and neuroinclusion. As the founder and CEO of Speak Up, a consulting firm specializing in healthcare delivery, mental health education, government relations, and policy analysis, Blady’s expertise is expected to contribute significantly to the PMPRB’s mission. While the federal government strengthens its regulatory oversight, provinces are also taking significant steps to boost healthcare innovation and economic growth. In a major move, the Ontario government has unveiled the next phase of its life sciences strategy, committing $146 million to bolster the province’s position as a global hub for biomanufacturing and health sciences innovation. This new investment builds upon $5 billion in investments and 5,000 jobs created since 2018, focusing on advancing R&D, improving capital access, ecosystem support, and driving healthcare innovation. Key allocations include $46 million for research infrastructure, $15 million for wet labs, and $24 million to scale up life sciences companies. Premier Doug Ford emphasized that the strategy will enhance Ontario’s biomanufacturing capacity and reinforce its status as a primary destination for life sciences investments. Ontario Economic Development Minister Vic Fedeli described the strategy as a “hard pivot” from electric vehicles to life sciences, aiming to increase life sciences jobs from 72,000 to 85,000 by 2030. He also emphasized Ontario’s potential as a leader in nuclear medicine due to its CANDU nuclear reactors and partnerships with leading universities and companies. While provincial initiatives like Ontario’s life sciences strategy aim to boost innovation and economic growth in healthcare, federal policy changes are reshaping the landscape of medication access across the country. The recent passage of Bill C-64, the Pharmacare Act, has ignited a heated debate about its potential impact on Canada’s healthcare system, particularly regarding the coverage of essential medications. While aiming to improve access to prescription drugs, the legislation has drawn criticism from key stakeholders in the healthcare industry. The Canadian Life and Health Insurance Association has voiced strong concerns, suggesting it could potentially jeopardize Canadians’ existing access to vital medications. Stephen Frank, the association’s president and CEO, described the Senate’s decision to pass the bill without amendments as “vague and confusing,” and a disregard for the concerns of stakeholders. As the debate over the Pharmacare Act continues, the federal government is moving forward with its implementation plans. Prime Minister Justin Trudeau announced that negotiations on pharmacare deals between provinces and territories must start as soon as possible after passing the Pharmacare Act into law, with Health Minister Mark Holland expressing confidence in securing agreements with all provinces by spring. The federal government aims to establish bilateral agreements providing universal, single-payer, first-dollar access to birth control and diabetes medications. As part of the implementation process, Holland is also tasked with creating a committee of experts who will make recommendations, which must be provided after a year of receiving Royal Assent. A pan-Canadian strategy detailing the appropriate use of prescription drugs and related products must also be published. Provincial responses vary, with Alberta expressing willingness to discuss despite skepticism, while Saskatchewan’s political parties remain divided on the issue. While pharmacare discussions dominate headlines, efforts to improve healthcare equity and accessibility continue at various levels. The federal government has announced a $2.7 million investment through the Enabling Accessibility Fund (EAF) to enhance accessibility for people with disabilities at the Luso Canadian Charitable Society in Mississauga, Ontario. This project will upgrade infrastructure with accessible washrooms, ramps, an elevator, and a drop-off area, while also creating job opportunities for persons with disabilities. In a related development, Ontario has marked a milestone with the establishment of the first Indigenous-led hospice, providing $1.25 million in funding for the construction of a five-bed hospice that will be used by the Six Nations of the Grand River. Looking beyond current initiatives to future challenges, an independent panel of doctors and researchers expressed the need for urgent preparation for the next health emergency, highlighting the government’s crucial role in taking action. The report stated the importance of effectively communicating disease surveillance, research findings, and hospitalization data between the federal government, provinces, and territories. The panel also emphasized that inequity among Indigenous communities, the homeless, and others during health emergencies should be addressed. As Canada’s healthcare landscape continues to evolve, these developments highlight the ongoing challenges and opportunities in improving healthcare access, equity, and preparedness across the country. Stay tuned to Delphic Research for further insights into these critical healthcare issues, or better, book a free consultation today!
Delphic Research Group Inc. expands Mitchell Pratt’s role to include Program Manager, Directory Assistance.
Delphic Research Group Inc. is pleased to announce that Mitchell Pratt, our Manager of Growth, has also been named Program Manager,Directory Assistance. In this new capacity, Mitch will oversee the development and execution of Delphic Research’s Directory Assistance division, which is dedicated to building knowledge around the people who matter most—decision-makers and influencers in the context of government affairs. The division leverages data-driven strategies to provide customers with superior intelligence,insights, and information about key stakeholders driving policy. As Program Manager, Mitch will take on responsibility for CanGov 411, the first and only application available on both iOS and Android that integrates government directories across Canada. He will lead the charge in developing data-driven stakeholder mapping, exploring predictive analytics, and tapping into behavioral science to offer enhanced tools that help clients better navigate the complex world of government affairs. Mitch’s appointment helps round out our developing program strategy, and he will join Mac Grenier, Program Manager for the Executive Daily Briefing and Subscription Services, and Emmanuel Duwana, Program Manager for The Academy,Delphic Research’s innovative learning management division. These are early days for these new programs, and we are very excited about their potential as we continue to build them out. Mitch brings a wealth of experience to this role. Before joining Delphic Research, he worked in a variety of positions, including at an early-stage startup where he focused on customer success, communications, and product partnerships. Prior to that, Mitch was part of EY Canada’s Business Transformation Consulting team, where he helped clients solve problems with data-driven storytelling. He also led client engagements at Impact Public Affairs and started his career in government relations at Crestview Strategy. His multifaceted background, combined with his strong skills in public affairs,stakeholder relationship management, and political communications, makes Mitch an ideal fit to lead the Directory Assistance division. Jason Grier, CEO of Delphic Research, shared his enthusiasm about Mitch’s expanded role: “I’m really pleased that Mitch is taking on these additional responsibilities. It’s indicative of our commitment to building products that help elevate government affairs through knowledge. We firmly believe that professionals deserve professional tools, and when it comes to government affairs, Delphic Research is at the forefront of building those tools.” At Delphic Research, we continue to elevate government affairs through innovative products, and Mitch’s leadership in Directory Assistance will be a key driver of that mission.
Weekly Top Stories: Mental Health Experts Call for Urgent Improvement in Public Accessibility
This week, Canada’s healthcare landscape saw a major policy shift alongside growing concerns about mental health accessibility and outcomes. Bill C-64, the Pharmacare Act, has reached a crucial milestone, receiving Royal Assent from the Governor General of Canada on October 10, 2024, following its third Senate reading. The Act, which will come into effect once the House of Commons Chamber is notified, marks a significant step towards a national universal pharmacare plan. It will initially cover diabetes and birth control medications, allowing the federal government to forge agreements with provinces and territories to incorporate these medications into the public health system. Health Minister Mark Holland, who sponsored the bill, is set to collaborate closely with provinces and territories in deciding bilateral agreements for universal and single-payer first-dollar coverage for medications as part of the first phase of the pharmacare program. British Columbia has already signed a memorandum of understanding with the federal government to launch the same program in the province. Notably, the bill was central to the political pact between the Liberals and the New Democratic Party (NDP). The NDP, however, ended the two-and-a-half-year supply-and-confidence agreement with Prime Minister Justin Trudeau’s party last September 4, 2024. While the Pharmacare Act represents progress in medication coverage, mental health experts are urgently calling for improved public accessibility to health services in Canada, as various reports highlight significant gaps in the current system. The Canadian Institute for Health Information reported that Canadians’ health is significantly affected by economic factors, citing a negative impact on their mental health due to financial concerns. The financial barrier between the public and mental healthcare also affects Canadians daily. This includes the lack of access to psychotherapy and counselling due to the exclusion of it from the country’s public healthcare system. Elisabeth Briere, in an opinion piece, emphasizes the need for accessible and inclusive mental health services, particularly for youth, as one-third of girls aged 16 to 21 are more prone to experience a decline in their mental health. The Canadian Alliance on Mental Illness and Mental Health (CAMIMH) reports that 90% of Canadians believe timely access to publicly funded mental health services is crucial, while 83% see a need for more mental health care providers across provinces. Further compounding the issue, a Canadian Mental Health Association report reveals that only 15% of the new federal money is earmarked for mental healthcare. Mental health concerns continue to be a pressing issue, as studies highlight the urgent need for rapid access to care and comprehensive support systems. A study by GreenShield, a national non-profit health and benefits provider, revealed that two-thirds of Canadian employees are likely to quit their jobs due to intense stress, anxiety, and burnout. The experience is more common to women and younger workers who are 18 to 24 years old. Employees are also seeking more comprehensive mental health benefits when applying. This trend is further emphasized by a survey from Pollara Strategic Insights and Workplace Strategies for Mental Health on behalf of the Canada Life Assurance Co. and Mental Health Research Canada, which reports that 69% of employees are experiencing burnout symptoms such as lower levels of motivation, reduced levels of energy, and feelings of irritability. Mental health experts Stan Kutcher and Alexa Bagnell stress the importance of prioritizing rapid access to mental health care, especially for young people who may experience severe mental disorders. Adding to the complex picture of mental health in Canada, a study published in JAMA Network Open has shed light on the significant mental health disparities faced by transgender and gender-diverse individuals. The research reveals that transgender individuals in Canada are three times more likely to experience severe mental health disorders, such as depression and anxiety, and face significantly higher rates of suicidal thoughts and attempts compared to their cisgender peers. Lead author Heidi Eccles emphasized the critical need for enhanced support and gender-affirming care to address this mental health crisis. Senior author Dr. Ian Colman underscored the importance of these findings in informing policy decisions aimed at improving mental health services for this marginalized community. The study’s results highlight the urgent necessity for targeted interventions and comprehensive support systems to address the unique mental health challenges faced by transgender and gender-diverse Canadians, calling for immediate action from healthcare providers and policymakers alike. Book a free consultation today to learn more about how these healthcare trends might impact your organization or community.
Weekly Top Stories: Pharmacare will be paid for through a public drug plan, according to Holland
This week has been full of heated debates over the future of Pharmacare. From alarming workforce shortages to urgent calls for reconciliation, the healthcare sector is facing unprecedented pressures on multiple fronts. The Pharmacare debate has intensified with Federal Minister Mark Holland’s recent declaration that the program will be a “universal, single-payer, first-dollar coverage plan.” In a letter to the Standing Senate Committee on Social Affairs, Science and Technology, Holland outlined that Canadians in participating provinces and territories may receive free diabetes and contraceptive medications, and the cost will be charged entirely to the public drug plan. The Canadian Life and Health Insurance Association swiftly responded, claiming Holland’s statement contradicted his previous testimony in the House and Senate. The association raised concerns about the uncertainty of Pharmacare’s impact on over 27 million Canadian workers and called on lawmakers to “take the time needed to get Bill C-64 right.” Adding to the debate, the Canadian Medical Association Journal published a letter by Chris Bonnett, describing publicly funded single-payer drug plans as impractical and advocating for the necessity of private insurance in Pharmacare. According to Bonnett, using mixed-payer models with a strong regulatory framework and governance may mitigate the risk to the federal government and the public. While policymakers grapple with a coverage plan, a troubling trend has emerged in emergency care. Up to 40% of Canadians reported skipping emergency room visits last year due to lengthy wait times, prompting urgent calls for improved hospital staffing. Advocates emphasize a “Respect, Retain, Recruit”approach to address this crisis. Simultaneously, the challenges facing Canada’s healthcare workforce have come into sharp focus. A report by three Canadian senators revealed a looming shortfall of over 50,000 family doctors by 2031, advocating for increased funding to train international medical graduates (IMG) to address this crisis. The proposal suggests adding 750 family physicians annually through expanded residency training and an assessment program for IMGs, requiring a $104 million investment from 2024 to 2025. Currently, 6.5 million Canadians lack a family doctor, a number projected to rise, leading to worse health outcomes and increased emergency room reliance. The report emphasizes the urgent need for systemic changes to effectively utilize the 13,000 IMGs who are currently unable to practice in Canada. In addition to this, new research from Workplace Strategies for Mental Health, supported by Canada Life, revealed that while burnout among Canadian workers has decreased from 35% in December 2021 to 24% today, it remains a pressing issue. The study highlights that 69% of workers are experiencing symptoms that could lead to burnout, with healthcare workers reporting the highest rates at 38%. Experts urge employers to continue implementing proactive strategies to alleviate workplace stressors and prevent burnout, emphasizing the importance of early intervention and available resources, including free virtual workshops on managing workloads and stress. Another interesting report from the Montreal Economic Institute highlighted a trend in Canada’s healthcare system. It revealed that 40% of nurses trained in 2022 left the profession before turning 35, a 25% increase in young nurse departures since 2013. As Canada anticipates a shortage of 117,600 nurses by 2030, experts stress the need for improved workplace flexibility to enhance retention, particularly in Ontario, where the departure rate has surged 83% over the last decade. Amidst these challenges, efforts towards reconciliation in healthcare are gaining momentum. The Canadian Medical Association (CMA) has unveiled the first stages of its ReconciliACTION plan. In a statement, CMA President Dr. Joss Reimer reiterated the organization’s commitment to implement the plan, which was developed in collaboration with Indigenous leaders to advance Indigenous health equity. The CMA recently apologized to First Nations, Inuit, and Métis Peoples for systemic racism in healthcare. Associate Professor Marcia Anderson, an Indigenous cultural safety and anti-racism advocate from the University of Manitoba Health Sciences faculty, regarded the CMA’s apology as meaningful for addressing the divide between the public and the medical profession as she reflected on her experiences with racism in the medical system. A recent report from the British Columbia First Nations Health Authority revealed a troubling drop in life expectancy for Indigenous people in the province, decreasing by over six years between 2017 and 2021, now standing at 67.2 years compared to 82.5 years for non-Indigenous individuals. Dr. Danièle Behn Smith, B.C. Deputy Provincial Health Officer for Indigenous Health, called for systemic changes in healthcare, including increased representation of Indigenous healthcare professionals and decision-makers. Whether you’re a healthcare professional, policymaker, or concerned citizen, understanding these developments is key to contributing to the ongoing dialogue about the future of healthcare in Canada. At Delphic Research, we remain committed to bringing you the latest insights to help you navigate this rapidly changing landscape. Book a free consultation today!
Weekly Top Stories: Pharmacare Could Threaten Economy, Says Drug Industry
In this week’s edition, we witness the heated Pharmacare debate that’s dividing industry stakeholders and unions, and the quiet revolution in dental care access sweeping across communities, our healthcare landscape surely is evolving at a dizzying pace. The Canadian healthcare system finds itself at a critical juncture, with the proposed Pharmacare program at the centre of a heated debate between industry stakeholders, public sector unions, and a public increasingly concerned about access to medical care. According to an article published in The Globe and Mail, major stakeholders in the drug industry warned that Pharmacare may threaten the “economic balance” between manufacturers, retailers, and insurance companies. Canadian Life and Health Insurance Association President Stephen Frank expressed that Pharmacare could pose “risk and uncertainty” to existing coverage. More specifically, University of British Columbia Research Chair Dr. Michael Law claimed that the bill could incentivize benefit sponsors to reduce coverage for diabetes and contraceptive medications, while forcing Canadians to file claims through public instead of private plans. In addition to this, the Neighbourhood Pharmacy Association of Canada stands to lose $43 million in annual revenue if a universal public plan is implemented. Advocating for a mixed-payer approach, Loblaw Cos. Ltd and Shoppers Drug Mart have conducted over 22 lobbying activities since Pharmacare was introduced. At the same time, Canadian Generic Pharmaceutical Association President Jim Keon expressed the need for more clarity to inform manufacturing decisions.In stark contrast, public sector unions and advocacy groups are rallying for swift implementation of Pharmacare. The National Union of Public and General Employees (NUPGE) urged parliamentarians to prioritize Canadians’ well-being by resisting Conservative leader Pierre Poilievre’s push for an immediate election, which they claim threatens the progress of critical measures like the new Pharmacare legislation. NUPGE President Bert Blundon emphasized that halting parliamentary work would jeopardize essential support for Canadians struggling with high medication costs, asserting that the Pharmacare Act is a vital step toward improving the healthcare system and must be enacted without delay. The Avalon Chapter of the Council of Canadians called on the provincial government to commit to the national pharmacare program as the Pharmacare Act nears Royal Assent. In an open letter delivered to the premier and health minister, they emphasized the importance of ensuring that all residents with a Medical Care Plan card can access prescription contraceptives and diabetes medications without out-of-pocket costs, coinciding with the upcoming World Contraception Day of Action. This debate is unfolding against a backdrop of growing public dissatisfaction with the current healthcare system. A recent survey by Navigator revealed that nearly half of Canadians feel their access to medical care has declined. This perception has opened the door to discussions about healthcare reform, with many Canadians open to a larger role for the private sector. However, concerns about private payments remain, with fears they may favour wealthier individuals. Advocacy groups demand government action to address surgical backlogs and enhance public healthcare. While the Pharmacare debate continues, another healthcare initiative is showing promising results. The Canadian Dental Care Plan (CDCP) is making significant strides in improving oral health access across the nation, with over 750,000 Canadians recently accessing dental care services. Health Minister Mark Holland emphasized the government’s commitment to expanding dental services and improving accessibility, particularly for underserved populations, as part of a broader initiative to enhance overall health outcomes across the nation. However, the Conservatives oppose the CDCP for Quebecers, despite the evident need for dental services among hundreds of thousands in the province. This stance continues even as many of their constituents are enrolling in the program, raising concerns about access to essential dental care. Over 2.4 million Canadians have enrolled in the CDCP, with 750,000 already receiving services. This achievement marks a significant milestone for improving oral health and overall well-being across the country. Amidst these ongoing healthcare debates and initiatives, Research Canada has unveiled its 2024 Leadership in Advocacy Award recipients, celebrating outstanding contributions to health research advocacy in the country. Dr. Leena Augimeri was honoured for her impressive four-decade career dedicated to child and youth mental health and crime prevention, highlighting the long-term impact of committed researchers in shaping healthier communities. JDRF Canada received recognition for its tireless advocacy in type 1 diabetes research, underscoring the crucial role that patient-focused organizations play in driving medical advancements. In a nod to the future of health research advocacy, Kaitlin Kharas was presented with the inaugural Emerging Leader in Advocacy Award for her influential work in shaping Canadian policies that support graduate students and postdoctoral researchers. These developments are not just reshaping the health sector; they’re sending ripples through industries far and wide, making it imperative for leaders across all sectors to stay informed and agile. Stay informed with Delphic Research, book a free consultation today!
Weekly Top Stories: Health Minister Mark Holland pushes Senate to pass Pharmacare without amendments
In this week’s edition, we cover urgent pushes for programs to innovations and sobering reflections on systemic issues. The healthcare landscape is evolving rapidly, and it is important that we keep an eye on developments that can affect not only us but also our industries. In a crucial move at the federal level, Health Minister Mark Holland is pressing the Senate to pass Bill C-64, the Pharmacare bill, without amendments. On September 18, Holland appealed to the the Senate Social Affairs, Science, and Technology Committee, emphasizing the bill’s complexity and urgency. Stemming from the now-defunct supply-and-confidence deal between the Liberal government and the New Democratic Party, the bill is set for a third reading vote on October 10. If passed, Holland will enter negotiations with provinces and territories to provide coverage for diabetes and contraceptive medications. In addition to this, the Council of Canadians submitted a briefing note to the Standing Senate Committee on Social Affairs, Science andTechnology, detailing its three recommendations on Pharmacare. The council echoed Holland’s call to pass the bill without tweaks, citing the immediate need for timely rollout. Additionally, the council proposed to attach observations to affirm a public, single-payer, universal drug plan and guard against conflicts of interest throughout the policy-making process. Meanwhile, Ontario is considering expanding pharmacists’ duties to include more minor ailments, such as sore throat and shingles, additional vaccines, and some lab tests, according to Global News. While pharmacists support the change as a means to alleviate pressure on the healthcare system, doctors, represented by the Ontario Medical Association, express concerns about the impact on care quality arguing that doctors are better trained to handle complex conditions. At the same time, the Ontario Pharmacists Association dismisses safety concerns as the government considers adding more ailments to pharmacists’ responsibilities. A recent Blue Cross study has revealed interesting trends in Canadians’ approach to health. While 72% of Canadians have attempted to improve their health over the past year, particularly among younger generations, nearly half, or 48%, are not seeking professional health support due to perceived barriers. This disconnect highlights a significant challenge in healthcare utilization. Across the country, provinces are addressing various healthcare issues with targeted initiatives. Newfoundland and Labrador has launched a website to support dementia patients and caregivers, backed by $3.5 million in annual funding. It provides resources on diagnosis, treatment options, and training for businesses to create more inclusive environments for those affected by dementia, addressing the needs of the province’s aging population, which currently has about 10,000 diagnosed individuals. Saskatchewan is set to introduce its first Interventional Tricuspid Valve Repair Program in 2025, investing $330,000 annually for specialized procedures at the Royal University Hospital in Saskatoon. Manitoba is improving access to primary care with its first Extended Hours Primary Care Clinic at Grace General Hospital. All of these in the hopes that this will help improve our healthcare system. While these provincial initiatives aim to address current healthcare challenges, the medical community is also taking steps to rectify historical injustices. The Canadian Medical Association (CMA) drew praise after formally apologizing for its role in the historical and ongoing mistreatment of Indigenous Peoples, acknowledging systemic racism and substandard care. In an opinion piece, The Globe and Mail health columnist André Picard said the CMA’s pledge to work collaboratively with Indigenous communities is the right way to pursue reconciliation, citing its ReconciliACTION plan to rebuild trust and improve healthcare. The path forward requires a delicate balance of efficiency, quality of care, and equity. As our healthcare landscape continues to evolve rapidly, staying informed about these changes is crucial not only for healthcare professionals but for all Canadians and industries affected by health policy decisions. Delphic Research’s Executive Daily Briefing can be your tool to navigate these complex developments, ensuring that you are always ahead of the curve. Book a free consultation today!